Neurocrine Biosciences (NBIX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist

120.270
-4.060-3.27%

Close Oct 31 16:00 ET

120.270
0.0000.00%

Post 20:02 ET

12.18BMarket Cap32.07P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Neurocrine Biosciences Inc : BMO Raises Target Price to $121 From $114
ReutersOct 31 10:44 ET
Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $170
Moomoo NewsOct 31 09:40 ET · Ratings
Evercore Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $175
Moomoo NewsOct 31 09:40 ET · Ratings
A Quick Look at Today's Ratings for Neurocrine Biosciences(NBIX.US), With a Forecast Between $136 to $192
Moomoo NewsOct 31 09:00 ET · Ratings
Neurocrine Biosciences Analyst Ratings
BenzingaOct 31 06:40 ET · Ratings
Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
Yahoo FinanceOct 31 01:09 ET

Comments

$Neurocrine Biosciences (NBIX.US)$ 130

$Neurocrine Biosciences (NBIX.US)$ 140

$Neurocrine Biosciences (NBIX.US)$
400M Current Liability
They will probably dilute shares to raise the cash, as ending cash balance was 170M for the quarter.

1

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Biotech Stock Catalyst Watchlist 👀

Biotech Stock Catalyst Watchlist 👀

16

3

3

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data